baber/WOPTO huggingface dataset:
Patent WO-2020113264-A1 (WO)
Title: Procédé et appareil pour traitement minéral
Inventor: CLEGG ROBERT
IPC: C22B3/04
Filed: 2019-12-04
Abstract: Un appareil de traitement chimique (10) comprend : au moins un récipient (10) comprenant : une entrée (12) pour un courant de traitement liquide ; un tuyau de sortie (14A) pour un courant de traitement liquide pour sortir du récipient (10) ; et une zone (16) occupée au moins partiellement par un gaz. La zone (16) communique avec le tuyau de courant de traitement de liquide de sortie (14A) pour éliminer le gaz d'accumulation de la zone (16) au courant de traitement de liquide de sortie. L'invention concerne également des procédés chimiques, tels que des procédés d'oxydation, à l'aide de l'appareil (10).
Patent AU-2019201032-A1 (AU)
Title: Chip assembly for reusable surgical instruments
Inventor: PENNA CHRISTOPHER
IPC: A61B90/98
Filed: 2019-02-14
Abstract: CHIP ASSEMBLY FOR REUSABLE SURGICAL INSTRUMENTS A chip assembly (100) for use in a surgical stapler (10), the chip assembly (100) comprising: a housing assembly (102) including a base member (110) defining a cavity (111) and an identification assembly (230) received within the cavity (111); and a plug assembly (104) configured to selectively engage the base member (110) of the housing assembly (102), the plug assembly (104) including a housing, a wire (150a, 150B) extending from the housing, a seal member (120) disposed within and extending from a distal end of the housing, and first and second contact members (160a, 160b) extending through the seal member (120) and from the housing, wherein the seal member (120) is configured to be frictionally received within the base member (110) to secure the plug assembly (104) to the housing assembly (102) in a fluid tight manner.
Patent AU-2019202858-A1 (AU)
Title: Methods for treating clostridium difficile infection and associated disease
Inventor: NYBORG ANDREW C
IPC: A61K39/40
Filed: 2019-04-24
Abstract: The invention features methods for treating Clostridium difficile infection (CDI), C. difficile associated disease, and symptoms thereof, featuring the use of antibodies having enhanced half-life that specifically bind C. difficile toxin A and/or toxin B. In one aspect, the 5 invention provides a method of treating a C. difficile infection or C. difficile-associated disease in a subject, the method involving administering to the subject a combination of an anti-C. difficile toxin A antibody and an anti-C. difficile toxin B antibody having an alteration that increases the half-life of one or both antibodies relative to anti-C. difficile toxin A and B antibodies lacking the alteration. In one aspect, the invention features a composition .0 comprising an equimolar mixture of an anti-toxin A antibody and an antitoxin B antibody. The invention provides kits for treating a C. difficile infection or symptoms thereof.
Patent AU-2019204804-A1 (AU)
Title: Multi-pole synchronous pulmonary artery radiofrequency ablation catheter
Inventor: CHEN SHAOLIANG
IPC: A61N1/32
Filed: 2019-07-04
Abstract: Abstract A multi-pole synchronous pulmonary artery radiofrequency ablation catheter, comprising: a control handle including an adjustment apparatus; a hollow catheter body comprising a cavity; and an annular ring, wherein a lead wire, a temperature sensing wire and a pull wire are arranged in the cavity; wherein a flexible end of the catheter body is connected to the annular ring, the adjustment apparatus adjusts the tension of the pull wire to change a curvature of the flexible end; a shape memory wire is arranged in the annular ring, and one end of the shape memory wire extends to an end of the annular ring and the other end of the shape memory wire passes through a root of the annular ring and is fixed on the flexible end of the catheter body; wherein the annular ring is provided with an electrode group comprising a first electrode of a first length, a second electrode of a second length different than the first length, and a third electrode, each electrode is connected to the lead wire and temperature sensing wire. WO 2016/007851 PCT/US2015/039930 C%4 CI\J C'
Patent AU-2019207851-A1 (AU)
Title: A thermodynamic system containing a fluid, and method for reducing pressure therein
Inventor: GALLINELLI LORENZO
IPC: F01K25/10
Filed: 2019-01-11
Abstract: A thermodynamic system containing a working fluid is disclosed. The thermodynamic system comprises at least a working fluid collection vessel (11) adapted to contain a liquid phase and a gaseous phase of the working fluid in thermodynamic equilibrium. A chilling arrangement (51) is functionally coupled to the fluid collection vessel (11) and adapted to remove heat from the working fluid collected in the working fluid collection vessel (11) and thereby reduce pressure in said thermodynamic system. Also disclosed are methods for depressurizing a thermodynamic system containing a working fluid in liquid/gas equilibrium.
Patent AU-2019218122-A1 (AU)
Title: Pancreatic cells for treating diabetes and methods of generating the same
Inventor: RUST WILLIAM L
IPC: G01N33/50
Filed: 2019-02-08
Abstract: The present disclosure provides cell-based compositions for treating diabetes, methods for identifying cells that preferentially differentiate into endoderm cells, and methods for preparing insulin-producing pancreatic cells, as well as related methods of use for treating diseases related to insulin deficiency.
Patent AU-2019225656-A1 (AU)
Title: Track pin and bushing retention design for a track chain
Inventor: JONES BENJAMIN I
IPC: B62D55/21
Filed: 2019-01-23
Abstract: A track chain member (200) may comprise a shoe member (206), and a first rail member (204a) extending from the shoe member (206). The first rail member (204a) may include a first lug (208) defining a first bore (210) defining a first longitudinal axis (L210) and including a first bushing retention shelf (212) disposed in the first bore (210), a second lug (214) including a second bushing retention shelf (218) disposed in the second bore (216). A third lug (222) may extend in a direction opposite that of the first lug (208) and second lug (214) and may be disposed axially between the first lug (208) and the second lug (214).
Patent AU-2019226713-A1 (AU)
Title: Transduction and expansion of cells
Inventor: KARADIMITRIS ANASTASIOS
IPC: C12N5/0783
Filed: 2019-02-28
Abstract: Provided is a method of transducing and expanding a population of cells, the method comprising, in order: a cell selection step; a pre-transduction activation step; a cell transduction step; and a cell expansion phase. At least the cell transduction step and the expansion phase comprise incubation of the cells with IL-15. The methods of the invention are well suited to the transduction and expansion of populations of cells expressing chimeric antigen receptors (CARs), and in particular for the transduction and expansion of populations of invariant natural killer T (iNKT) cells expressing CARs. Also provided are populations of cells produced by the methods of the invention,and pharmaceutical compositions comprising populations of cells, as well medical uses of the pharmaceutical compositions and populations of cells. The cells and pharmaceutical composition are suitable for application in medical use and methods of treatment, including immunotherapy.
Patent AU-2019238344-A1 (AU)
Title: Device for suture attachment for minimally invasive heart valve repair
Inventor: CAFFES LEVI
IPC: A61B17/04
Filed: 2019-03-25
Abstract: In one embodiment, a suture attachment catheter configured to repair a heart valve by inserting a suture in a valve leaflet of a beating heart of a patient includes a handle control, a flexible catheter body and a suture attachment assembly at a distal end of the catheter body. The suture attachment assembly can include a rail between a distal clamping jaw hingedly attached to the rail, and a proximal clamping jaw. One of the proximal clamping jaw or distal clamping jaw can be selectively slideable with respect to the other on the rail using a jaw actuator of the control handle to adjust a distance between the proximal clamping jaw and the distal clamping jaw. A needle can be selectively slideable within the catheter body by using a needle actuator of the proximal handle control to penetrate a valve leaflet and insert a suture through the valve leaflet when the valve leaflet is captured between the proximal clamping jaw and the distal clamping jaw.
Patent AU-2019256431-A1 (AU)
Title: Anti-ror antibody constructs
Inventor: BAILEY LUCAS
IPC: A61K45/06
Filed: 2019-04-18
Abstract: Anti-ROR antibody constructs, pharmaceutical compositions comprising the constructs, and methods of use thereof are presented.
Patent AU-2019284649-A1 (AU)
Title: Chimeric antigen receptor tumor infiltrating lymphocytes
Inventor: MULÉ JAMES
IPC: C12N15/00
Filed: 2019-06-12
Abstract: Disclosed are compositions and methods for targeted treatment of infections and cancers expressing cancers. In particular, tumor infiltrating lymphocytes (TILs) are genetically engineered to express chimeric antigen receptor (CAR) polypeptides to produce CAR-TILs that can be used with adoptive cell transfer to target, penetrate, and kill solid tumor masses. Therefore, also disclosed are methods of providing an immunotherapy in a subject with an infection or cancer that involves adoptive transfer of the disclosed CAR-TILs.
Patent AU-2019285616-A1 (AU)
Title: Blockchain-based set exchange method and apparatus for available resource quotas
Inventor: YANG XINYING
IPC: G06Q20/40
Filed: 2019-02-22
Abstract: Disclosed are a blockchain-based set exchange method and apparatus for available resource quotas. A blockchain network comprises a management node and object nodes, wherein each object node performs copyright use transactions by taking virtual resources issued by the management node as transaction media. One object node may serve as a user party to provide the virtual resources in some copyright use events, or may serve as a creation party to receive the virtual resources in some copyright use events. For any object node set, when the object node set is selected as a target object by the management node, each object node in the object node set is capable of acquiring certain available resource quotas for determining earning increments corresponding to the object node itself. In addition, the available resource quotas distributed to one object node need to be exchanged by using the virtual resources possessed by the object node.
Patent AU-2019299453-A1 (AU)
Title: System for deliverables versioning in audio mastering
Inventor: MORRIS STEPHEN
IPC: G10L25/57
Filed: 2019-07-02
Abstract: Implementations of the disclosure describe systems and methods that leverage machine learning to automate the process of creating various versions of sound mixes using an original sound mix as a starting point. In implementations, a system for automated versioning of sound mixes may include: (i) a component to extract metadata categorizing/identifying the input sound mix; (ii) a component to extract audio features of the input sound mix; (iii) a component that uses a machine learning model to compare the extracted audio features of the input sound mix with extracted audio features of previously analyzed sound mixes to calculate audio features of a target sound mix; and (iv) a component to perform signal processing to derive the target sound mix given the calculated audio features.
Patent AU-2019301627-A1 (AU)
Title: Power-efficient discovery process for nodes within a wireless mesh network
Inventor: UHLING THOMAS
IPC: H04L45/122
Filed: 2019-07-09
Abstract: A wireless network includes a plurality of nodes configured to implement an improved discovery process to efficiently and reliably pair with one another with low power consumption. A given node divides time into slots and then performs discovery operations during designated discovery windows. The discovery windows occur periodically but at different times of day. During a given discovery window, nodes attempt discovery using a reduced set of channels that varies from one window to the next, thereby increasing the likelihood that nodes operate on the same channel. Nodes also implement a pairing protocol to coordinate pairing, potentially avoiding situations where all nodes attempt to pair simultaneously. The discovery process may be completed expeditiously, thereby conserving power and extending the operational lifetime of nodes which rely on battery power.
Patent AU-2019320708-A1 (AU)
Title: Tubular connector
Inventor: KLUSS WILLIAM V
IPC: F16L37/084
Filed: 2019-04-04
Abstract: A connector includes a connecting body with a fluid passage at least part way therethrough, and a seal is provided with an outer portion of a fluid tube. A cartridge proximate to the connecting body has a hollow portion therethrough. A grab part has at least one tooth to retain the fluid tube and is between the cartridge and the seal. A demount part within the hollow portion moves the teeth to allow release of the fluid tube. A latch is located on one of the connecting body or a sleeve covering at least part of the cartridge or the connecting body. A mating catch is located on the other of the sleeve or the connecting body, and engagement of the latch with the catch connects the sleeve to the connecting body and helps restrain cartridge movement.
Patent AU-2019341266-A1 (AU)
Title: Antibody for specifically binding to Lysyl-tRNA synthetase N-terminal domain exposed to extracellular membrane
Inventor: KIM SUNGHOON
IPC: C07K16/40
Filed: 2019-09-17
Abstract: The present invention relates to an antibody for specifically binding to a Lysyl-tRNA synthetase N-terminal domain exposed to an extracellular membrane and, more specifically, to an antibody or a fragment thereof that specifically binds to a Lysyl-tRNA synthetase (KRS) N-terminal domain exposed to an extracellular membrane having a specific complementarity determining region (CDR) sequence described in the present specification, and use of a composition comprising the antibody or the fragment thereof as an active ingredient for preventing, treating, or diagnosing cancer, cancer metastasis, or immune cell migration-related diseases. The method of the present invention may be utilized to prepare an antibody with a higher affinity at a KRS N-terminus than existing antibodies.
Patent AU-2019357504-A1 (AU)
Title: Methods for treating or preventing skin conditions
Inventor: CHUNG CHRISTINA L
IPC: A61K31/436
Filed: 2019-10-10
Abstract: The present invention includes methods and compositions for preventing and treating certain skin disorders caused due to UV-induced, age-related, and post-inflammatorycutaneous changes. The skin disorders include, for example, static wrinkles, fine wrinkles, loss of skin tone, ephelides, melasma, senile purpura, UV-damage to the skin, static rhytides, prominent hand veins, field cancerization of epithelium such as in squamous cell carcinoma in situ, keloids, and imbalance in ratio of collagen isoforms. In certain embodiments, the compositions useful within the invention comprise a therapeutically effective amount of a rapamycin and a dermatologically acceptable carrier.
Patent AU-2019360351-A1 (AU)
Title: Apparatus for validatable output of images
Inventor: HILKEN CHRISTOPH
IPC: H04N7/18
Filed: 2019-10-14
Abstract: The invention relates to a device for the validatable output of images, comprising a number of screens for outputting images based on image data and a number of camera devices. Each camera device comprises a camera for providing image data based on a capturing of camera images, and an integration unit for outputting extended image data based on an integration of an encoded information block having a source reference specific to the camera and a time stamp specific to the capture. The device also comprises a transmission channel connected between the screens and the camera devices for transmitting the extended image data from the camera devices to the screens, and a validation unit that can be coupled to the screens for validating the image data that is transmitted via the transmission channel and extended based on the integrated information block.
Patent AU-2019378353-A1 (AU)
Title: Syringe suitable for hydrogen peroxide solution, and kit
Inventor: YAMASHITA SHOGO
IPC: A61J1/06
Filed: 2019-10-18
Abstract: Provided is a syringe which inhibits hydrogen peroxide from decomposing. The syringe includes a part where the syringe comes into direct contact with the hydrogen peroxide solution, the material of the syringe part being a cycloolefin polymer (COP) or a cycloolefin copolymer (COC).
Patent AU-2019378883-A1 (AU)
Title: Fusosome compositions for T cell delivery
Inventor: VON MALTZAHN GEOFFREY A
IPC: A61K9/127
Filed: 2019-11-14
Abstract: The present disclosure provides, at least in part, methods and compositions for in vivo fusosome delivery. In some embodiments, the fusosome comprises a combination of elements that promote specificity for target cells, e.g., one or more of a fusogen, a positive target cell- specific regulatory element, and a non-target cell- specific regulatory element. In some embodiments, the fusosome comprises one or more modifications that decrease an immune response against the fusosome.
Patent AU-2019424397-A1 (AU)
Title: Video image transmission method, device, interactive intelligent tablet and storage medium
Inventor: YANG MING
IPC: H04N21/4788
Filed: 2019-12-24
Abstract: The present application relates to a video image transmission method, device, an interactive intelligent tablet and storage medium. The method includes: acquiring the video image captured by a first video communication terminal; acquiring the semantic information in the video image; sending the semantic information to a second video communication terminal; the semantic information is used to reconstruct the reconstructed image of the video image at the second video communication terminal.
Patent WO-2020252537-A1 (WO)
Inventor: HUANG TAO
IPC: A61K38/00
Filed: 2020-06-19
Abstract: An antimicrobial agent comprising a selenium nanoparticle (SeNP) core and one or more superficially located antimicrobial peptide/s (AMP). The or each AMP may comprise an excess of positively charged amino acids compared to negatively charged amino acids and the AMP may comprise peptides from classes selected from polylysine, such as ε-poly-L-lysine (ε-PL), polyarginine, aurein, ovispirin, melittin, magainin, cecropin, andropin, moricin, ceratotoxin, melittin, magainin, dermaseptin, bombinin, brevinin, esculentins, buforin, cathelicidin, abaecin, apidaecin, prophenin and indolicidin. Products comprising such agents, methods of producing the agents and methods of killing or retarding growth of microorganisms exposed to the agents are also disclosed.
Patent WO-2021046592-A1 (WO)
Title: An armed unmanned aerial vehicle and methods of use thereof
Inventor: CREAGH MICHAEL
IPC: B64C27/28
Filed: 2020-09-07
Abstract: The present invention relates to an armed unmanned aerial vehicle ("UAV"), an armed UAV control system, and methods of use thereof. In one form, the armed UAV includes: an elongate body, a pair opposed side rotor arm assemblies extending from the sides of the body, a tail rotor arm assembly extending from a rear end of the body, a weapons system including at least one firearm associated with the body, and a flight and targeting controller operatively associated with the side rotor arm assemblies and the tail rotor arm assembly. The controller configured to: determine at least a pitch angle and yaw angle required to strike a target with the weapons system, based on target information received; and selectively control operation of each rotor arm assembly for aiming the weapons system, based on at least the pitch angle and the yaw angle determined.
Patent AU-2020229848-A1 (AU)
Title: Improved process for DNA integration using RNA-guided endonucleases
Inventor: DING BEIBEI
IPC: A61K39/00
Filed: 2020-02-27
Abstract: There is disclosed an improved, safer and commercially efficient process for developing genetically engineered cells. More specifically, there is disclosed a process comprises introducing a donor DNA construct, a guide RNA, and an RNA-guided nuclease with the host cells to he transfected; and introducing the three components into the host cell. There is further disclosed a donor DNA construct designed for inserting a CAR (chimeric antigen receptor) into a defined genomic site of a host cell. Further, the present disclosure provides a host cell transfected with a CAR that lacks viral vectors that can present a safety concern. The disclosure provides for more efficient and more cost-effective process for engineering T cells to express CAR constructs.
Patent AU-2020230273-A1 (AU)
Title: Femoral component
Inventor: ROLBIECKI PATRYK
IPC: A61F2/38
Filed: 2020-09-09
Abstract: A femoral component (2) for mounting onto a femur and being 
adapted to articulate with a tibial bearing component in a knee 
prosthesis comprises proximal end portions (7, 10) adapted to 
be oriented towards the femur when the femoral component (2) is 
mounted thereon, and distal end portions adapted to be oriented 
towards the tibial bearing component when the knee prosthesis 
is fully extended. The proximal end portions (7) comprise 
posterior proximal end portions which are located on an 
posterior side of the femoral component and an anterior proximal 
end portion (10) which is located on an anterior side of the 
femoral component (2). The femoral component (2) further 
comprises a medial condyle (13) and a lateral condyle (14) which 
each extend from one of the posterior proximal end portions 
beyond the distal portions and towards the anterior proximal end 
portion (10) of the femoral component (2). The medial and lateral 
condyles (13, 14) form a condylar gap between each other, wherein 
the medial condyle (13) and the lateral condyle (14) are shaped 
to articulate with the tibial bearing component through a range 
of motion, in which a full extension of the knee prosthesis 
corresponds to zero degrees flexion of the knee prosthesis and 
positive flexion corresponds to greater than zero degrees 
flexion of the knee prosthesis. The femoral component (2) 
further comprises a sagittal plane extending in a 
proximal/distal direction and further extending through the 
condylar gap from the anterior side to the posterior side of the 
femoral component (2). A patellar groove (16) extends from the 
condylar gap towards the anterior proximal end portion (10) of 
the femoral component (2) along a mathematical curve (17). The 
mathematical curve (17), when looking onto the anterior side of 
the femoral component, is canted towards a medial side (18) of 
the femoral component (2) relative to the sagittal plane when 
the patellar groove (16) extends proximally.  
Fig 4
1/4 
Fig.1 
1 
14 
3 
13 4
Patent AU-2020261425-A1 (AU)
Title: Mount for an article of wear
Inventor: GRINNELL EDWARD
IPC: H04N5/225
Filed: 2020-04-24
Abstract: A mount for coupling to an article of wear comprises a back plate configured to engage a front plate over the article of wear. The back plate comprises a first structure and a second structure. The front plate comprises a base configured to receive an accessory, a slide slidably engaged with the base, and a swing rotatably engaged with the base. The base comprises a third structure and a first latch feature. The slide comprises a fourth structure and a first coupler. The swing comprises a second coupler and a second latch feature. The slide is configured to move to engage the third structure with the first structure and the fourth structure with the second structure. The swing is configured to rotate to engage the first coupler with the second coupler and the first latch feature with the second latch feature.